AbbVie Inc. (ABBV) is currently at $66.43, down $12.02 or 15.32%

 

-- Would be lowest close since May 31, 2017, when it closed at $66.02

-- Would be largest percent decrease on record (Based on available data back to Dec. 10, 2012)

-- Earlier Tuesday, AbbVie Inc. agreed to buy Allergan PLC for about $63 billion. The takeover is worth about $188 a share in cash and stock, the companies said in a statement

-- Worst two day stretch on record (Based on available data back to Dec. 10, 2012)

-- Down 13.39% month-to-date; on pace for worst month since October 2018 when it fell 17.69%

-- Down 27.94% year-to-date

-- Down 46.08% from its all-time closing high of $123.21 on Jan. 26, 2018

-- Down 27.88% from 52 weeks ago (June 26, 2018), when it closed at $92.12

-- Down 32.79% from its 52 week closing high of $98.84 on July 10, 2018

-- Would be a new 52 week closing low

-- Traded as low as $66.29; lowest intraday level since June 1, 2017, when it hit $66.12

-- Down 15.5% at today's intraday low; largest intraday percent decrease since Oct. 22, 2015, when it fell as much as 15.57%

-- Worst performer in the S&P 500 today

-- Most active stock in the S&P 500 today

 

All data as of 10:37:00 AM

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 25, 2019 10:58 ET (14:58 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more AbbVie Charts.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more AbbVie Charts.